A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that ...

US FDA lifts clinical hold on PORTOLA phase 2a trial of Kezar Life Sciences for evaluating zetomipzomib to treat autoimmune hepatitis: South San Francisco, California Friday, July ...

Many of us instinctively understand the positive effects of nature on our health and well-being, yet our lives are often too ...

His family’s history with the disease has inspired his most recent activism.

Regulatory upheaval in the US and a venture capital drought are dampening investor appetites, but there are still diamonds in ...

Researchers report that eight healthy babies were born with the help of an experimental technique that uses DNA from three ...

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is one of the best oversold NASDAQ stocks to buy now. In a report released on ...

The FDA has lifted one of the two clinical holds placed on Kezar Life Sciences’ zetomipzomib, leading the biotech to speculate on whether to reignite another program for the same drug that remains ...

Kezar Life Sciences said a partial clinical hold on a trial for its zetomipzomib program to treat autoimmune hepatitis has been lifted by the Food and Drug Administration. The FDA lifted the hold ...

Investing.com -- Kezar Life Sciences Inc (NASDAQ: KZR) stock gained 4% after the FDA lifted a partial clinical hold on its completed Phase 2a trial evaluating zetomipzomib in patients with autoimmune ...

Lawrence General Hospital and Holy Family Hospitals in Methuen and Haverhill are having a job fair this Friday for all ...

THE Baltic Sea Darts Open is into the semi-finals and heading for a thrilling climax with a new champion guaranteed TONIGHT ...